What Techtrials - Healthcare Data Science does

Techtrials is a Brazilian healthcare data science company founded in 2009 and headquartered in São Paulo that operates a proprietary Real-World Evidence (RWE) platform to integrate, process, and analyze fragmented health data at scale. The platform architecture spans six modules — Ingestion (multi-source connection to EHRs, hospital systems, and public/proprietary databases), Engineering (proprietary ETLs, deduplication, standardization), Data Warehouse (governed storage), AI & Analytics (ML, NLP, GenAI, predictive modeling), Products (insight generation), and Decision (actionable intelligence). The company claims 10B+ records integrated and hundreds of millions processed with performance and traceability, forming a data foundation that supports three core SaaS products: EpiMarket (pharmaceutical intelligence covering epidemiology, market sizing, HEOR, and market access), Genius Hospital (AI/GenAI-powered hospital operational intelligence with dashboards and benchmarking), and Bed Predictor (predictive AI for hospital admissions and bed management). A Custom Enterprise Special Projects offering addresses high-complexity bespoke engagements including AI copilots, strategic observatories, and custom intelligence engines.

The company serves six customer segments: pharmaceutical companies (primary), hospitals and health networks (primary), government and public health agencies (primary), payers and health plans, research institutions, and strategic partners. The go-to-market is consultative enterprise field sales with engagement initiated through demos, specialized consultations, and dedicated contact channels, reflecting the high-complexity, high-touch nature of healthcare data implementations. Revenue streams combine SaaS platform subscriptions (recurring), enterprise custom projects (professional services), and strategic consulting. Techtrials operates with 51-100 employees and is privately held with no disclosed institutional investors or parent entity, having completed 500+ enterprise projects over its 15+ year history and maintaining dozens of peer-reviewed scientific publications in journals including JCO Global Oncology, The Lancet Regional Health Americas, Vaccines, and Crohn's & Colitis 360. The company holds LGPD (Brazilian data protection law) and GDPR compliance certifications, enabling both domestic Brazilian operations and potential international data processing engagements.

The business is self-sustaining rather than venture-backed, with no material funding rounds disclosed beyond a single 2021 round of unknown amount. Geographic footprint is concentrated in Brazil with bilingual (Portuguese/English) platform infrastructure suggesting international expansion intent, though no international customers are named. Recognition includes KPMG Global Tech Innovator Top 20 Global, 100 Open Startups Top 3 Healthtech, and USP SciBiz Award, providing third-party validation of innovation credibility.

Name

Techtrials - Healthcare Data Science

Legal name

Techtrials

Website

https://ttrials.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

Techtrials is a Brazilian healthcare data science company operating a proprietary Real-World Evidence platform that integrates 10B+ health records to deliver AI-powered SaaS products (EpiMarket, Genius Hospital, Bed Predictor) and custom AI solutions for pharmaceutical companies, hospital networks, government, payers, and research institutions.

Ownership category

akta.pro rank

Product category

Healthcare Real-World Evidence Analytics

NAICS

Computer Systems Design and Related Services (54151), Other Computer Related Services (541519)

SIC

Services-Computer Integrated Systems Design (7373), Services-Computer Programming Services (7371)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

Healthcare Data Integration, ETL/ELT & Pipeline Orchestration (HLACAIAC), Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC)

Keywords

• Real-world evidence platform
• Healthcare data analytics
• Pharmaceutical intelligence software
• Hospital analytics platform
• Predictive healthcare AI

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Platform Subscriptions: Proprietary platforms (EpiMarket, Genius Hospital, Bed Predictor) offered as scalable SaaS solutions with subscription-based access for pharmaceutical, hospital, and healthcare organization clients.
2. Enterprise Custom Projects: High-value custom AI projects built under contract for unique, high-complexity healthcare challenges, involving data integration, AI copilots, observatories, and tailored intelligence engines.
3. Enterprise Consulting: Strategic consulting engagements translating technical depth into business impact for pharma, hospitals, government, and strategic partners, with clear ROI focus.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Techtrials integrates large volumes of fragmented health data, applies AI and advanced analytics, and delivers proprietary SaaS platforms and custom enterprise solutions that turn real-world evidence into actionable intelligence for pharmaceutical companies, hospitals, government agencies, payers, research institutions, and strategic partners. Its core product set comprises EpiMarket (pharmaceutical intelligence), Genius Hospital (hospital intelligence), and Bed Predictor (predictive AI for bed management), all powered by a six-stage proprietary RWE platform spanning ingestion, engineering, warehousing, AI/analytics, products, and decision support.

Product overview

Techtrials operates a platform-plus-modules architecture centered on a proprietary Real-World Evidence (RWE) platform that ingests, engineers, and analyzes multi-source health data at scale. The product portfolio comprises three core SaaS products — EpiMarket (pharmaceutical intelligence), Genius Hospital (hospital intelligence), and Bed Predictor (predictive AI for bed optimization) — supplemented by Custom Enterprise Special Projects for high-complexity, tailor-made AI solutions. All products share the underlying RWE platform infrastructure for data ingestion, engineering, warehousing, and AI/analytics capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• EpiMarket: Health intelligence platform based on real-world data for the pharmaceutical industry, covering epidemiology, market sizing, patient journey, HEOR, and market access.
• Genius Hospital
• Bed Predictor

Products and services

• EpiMarket A pharmaceutical intelligence SaaS platform that delivers real-world epidemiology, market sizing, patient journey analysis, therapeutic behavior insights, HEOR, market access support, and data-driven medical affairs forecasting for pharmaceutical industry clients.
• Genius Hospital A hospital intelligence SaaS platform using AI and GenAI to provide advanced dashboards, benchmarking, strategic KPIs, real-time analytics, action plans, and risk-sharing capabilities for operational gains and clinical decision support at hospital systems and health networks.
• Bed Predictor A predictive AI SaaS solution that forecasts hospital admissions and optimizes bed management, enabling demand prediction, management optimization, bottleneck reduction, and intelligent resource allocation for hospitals and health systems.
• Special AI Projects (Custom Enterprise Engagements) A custom enterprise service that integrates data, AI, large language models, and automation to deliver bespoke AI solutions for high-complexity healthcare challenges, including AI copilots, conversational dashboards, strategic observatories, war rooms, custom intelligence engines, and healthcare process automation for pharmaceutical, hospital, government, and strategic partner clients.

Quantifiable outcome

• Centenas de milhões of records processed with performance and traceability
• +4 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: IQVIA is the global leader in RWE, HEOR, and pharma market intelligence, with deep ties to pharma commercial and clinical teams. Highly comparable to Techtrials' EpiMarket offering, though operating at vastly larger scale across multiple geographies.
• Flatiron Health: Flatiron Health (acquired by Roche) is a leading US oncology RWE platform that aggregates EHR data for research and clinical decision support. Comparable to Techtrials' oncology and hospital data work, though focused on US providers and oncology-specific.
• Tempus Labs: Tempus combines multimodal health data with AI to support precision medicine and clinical decisioning. Overlapping with Techtrials on AI + structured health data analytics, though focused on genomics and US clinical care.

Direct peers

• TriNetX: TriNetX operates a global RWE network connecting hospitals and pharma for observational research and clinical trial design. Directly comparable to Techtrials' platform-plus-data-network approach with similar pharma and hospital customer segments.
• Aetion: Aetion provides an RWE analytics platform used by pharma, payers, and regulators for evidence generation and HEOR. Closely comparable to Techtrials' EpiMarket and decision-support capabilities in pharma RWE.
• Komodo Health: Komodo Health maps patient journeys using de-identified longitudinal health data and offers software for pharma, payers, and providers. Directly competes with Techtrials on patient journey analytics and healthcare intelligence at broader scale.
• Datavant: Datavant specializes in healthcare data connectivity and de-identification, enabling patient-level record linkage across fragmented sources. Directly comparable to Techtrials' data engineering and integration layer powering RWE analytics.

Emerging players

• Mendel: Mendel applies AI to unstructured and structured clinical data for pharma R&D and operational use cases. Emerging player with meaningful overlap on AI-based health data analytics for pharma customers.

Regional players

• MV Sistemas: MV Sistemas is a leading Brazilian hospital information systems vendor serving large hospital networks in Brazil. Regional peer relevant to Techtrials' Genius Hospital and Bed Predictor offerings within the same Brazilian hospital buyer base.
• Pixeon: Pixeon is a Brazilian healthcare technology company offering HIS, LIS, and imaging systems for hospitals and labs. Comparable regional player for hospital-side data and analytics opportunities in Brazil, though focused on transactional rather than analytical systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/techtrials

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Techtrials - Healthcare Data Science